Fairfield Bio, Inc. — Form D

Fairfield Bio, Inc. of BRONX, NY, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-12. The offering totals $2.0M, of which $450K was reported sold. Industry: Other.

Offering

• Filed: 2026-02-12
• Form: D
• Accession: 0002110597-26-000001
• Industry: Other
• Exemptions: 06b
• Total offering: $2.0M
• Amount sold: $450K
• Remaining: $1.6M
• Investors: 1
• Date of first sale: 2026-01-26
• Revenue range: Decline to Disclose
• SEC file number: 021-573452

Issuer

• Name: Fairfield Bio, Inc.
• CIK: 0002110597
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2025
• Address: 5454 PALISADE AVENUE, BRONX, NY, 10471
• Phone: 6467094770

Officers, directors & promoters (4)

More

• CIK 2110597 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search